Search results for " sleep apnea"

showing 10 items of 173 documents

Impact of Bimaxillary Advancement Surgery on the Upper Airway and on Obstructive Sleep Apnea Syndrome: a Meta-Analysis

2018

AbstractUpper airway changes following bimaxillary advancement surgery to treat obstructive sleep apnea syndrome remain controversial. The main objective of this systematic review and meta-analysis was to investigate the effects of bimaxillary advancement surgery on the upper airway (UA) of obstructive sleep apnea syndrome patients through examining changes three-dimensionally in vertical and supine position and through changes in oximetric variables (AHI, RDI, O2 Sat) and in the quality of life measured by the Epworth sleepiness scale (ESS). A thorough search of the PubMed, Scopus, Embase and Cochrane databases and a grey literature search (Opengrey) were conducted. No limit was placed on …

Adultmedicine.medical_specialtySupine positionScienceNoseArticle03 medical and health sciencesOrthognathic Surgical Procedures0302 clinical medicineQuality of lifeHumansMedicineOximetry030223 otorhinolaryngologySleep Apnea ObstructiveMultidisciplinaryOrthognathic Surgical Proceduresbusiness.industryEpworth Sleepiness ScaleQRSleep apnea030206 dentistrymedicine.diseaserespiratory tract diseasesSurgeryObstructive sleep apneaTreatment OutcomeMeta-analysisQuality of LifeMedicineLarynxbusinessAirwayScientific Reports
researchProduct

Relationship Between the Apolipoprotein E Genotype and LDL Particle Size in Patients With Obstructive Sleep Apnea.

2016

Obstructive sleep apnea (OSA) is associated with dyslipidemia and increased cardiovascular risk. We assessed the effects of apolipoprotein E ( APOE) genotype on low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particle size and lipid subclasses (separated by gradient gel electrophoresis) in patients with OSA. Stable patients (n = 181) prospectively recruited underwent full polysomnography. Both LDL particle size and LDL I proportion were reduced from ∊3∊3 homozygotes to ∊2 carriers and to ∊4 carriers (analysis of variance: P = .024; P = .040, respectively); carriers of the ∊4 allele of the APOE genotype had significantly lower LDL particle size and LDL I proportion compared…

Apolipoprotein EAdultMalemedicine.medical_specialtyGenotypePolysomnographyApolipoprotein E4Statistics as TopicPolysomnography030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInsulin resistanceApolipoproteins EInternal medicineGenotypemedicineHumansGenetic Predisposition to Disease030212 general & internal medicineProspective StudiesParticle SizeAgedSleep Apnea Obstructivemedicine.diagnostic_testbusiness.industryGenetic Carrier ScreeningMiddle Agedmedicine.diseaseObstructive sleep apneaLipoproteins LDLEndocrinologyCardiovascular Diseaseslipids (amino acids peptides and proteins)FemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessDyslipidemiaLipoproteinAngiology
researchProduct

Sleep Apnea, Sleepiness, and Driving Risk

2019

Obstructive sleep apnea is associated with excessive daytime sleepiness in about 50% of cases, and with increased risk of driving accidents. Treatment with continuous positive airway pressure effectively decreases such risk, but compliance with continuous positive airway pressure treatment is often suboptimal. According to the European Union Directive on driving risk, retention of a driving license in patients with obstructive sleep apnea requires assessment of sleepiness and adherence to continuous positive airway pressure treatment, but there remains uncertainty on the optimal methods to assess sleepiness on a large scale.

Automobile Drivingmedicine.medical_specialtySleepinessmedicine.medical_treatmentDriving riskExcessive daytime sleepinessSubjective sleepineSettore MED/10 - Malattie Dell'Apparato RespiratorioObjective sleepine03 medical and health sciencesSleep Apnea SyndromesSleep Apnea Syndrome0302 clinical medicineRisk FactorsCPAPEpidemiologymedicineHumansmedia_common.cataloged_instanceContinuous positive airway pressureWakefulnessEuropean unionobstructive sleep apneapathophysiologymedia_commonContinuous Positive Airway Pressurebusiness.industryRisk FactorWakefulneSleep apneaGeneral Medicinemedicine.diseasesubjective sleepinessrespiratory tract diseasesObstructive sleep apneaPsychiatry and Mental healthClinical PsychologyNeuropsychology and Physiological Psychology030228 respiratory systemEmergency medicineobjective sleepinessPatient ComplianceepidemiologyNeurology (clinical)medicine.symptombusinessOptimal methods030217 neurology & neurosurgeryHumanSleep Medicine Clinics
researchProduct

Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine.

2022

We recruited 5,970 patients with hypertension with obstructive sleep apnea (OSA) on current antihypertensive treatment from the European Sleep Apnea Database (ESADA) cohort. The group was subdivided into those receiving monotherapy (n = 3,594) and those receiving dual combined therapy (n = 2,376). We studied how major OSA confounders like age, gender, and body mass index as well as the degree of sleep apnea modified office systolic and diastolic blood pressure. Beta-blockers alone or in combination with a diuretic were compared with other antihypertensive drug classes. Monotherapy with beta-blocker was associated with lower systolic blood pressure, particularly in non-obese middle-aged male…

Behavioral NeurosciencehypertensionCognitive Neurosciencediureticbeta-blockerobstructive sleep apnea.General MedicineSettore MED/10 - Malattie Dell'Apparato Respiratorioantihypertensive treatmentJournal of sleep researchREFERENCES
researchProduct

Pulmonary haemodynamics in obstructive sleep apnoea.

1995

In patients with obstructive sleep apnoea syndrome (OSAS), pulmonary haemodynamics can show both transient perturbations during sleep and permanent alterations. During sleep, repeated fluctuations in pulmonary artery pressure and pulmonary wedge pressure, coincident with apnoeas, can be observed. Calculation of transmural pressure values is preferable to intravascular pressures in OSAS, due to the marked swings in intrathoracic pressure associated with obstructive apnoeas. Pulmonary artery pressure may progressively increase during sleep, particularly in close sequences of highly desaturating apnoeas. Apnoea-induced hypoxia appears as the most important determinant of this pulmonary artery …

Cardiac outputPulmonary and Respiratory MedicineCardiac outputmedicine.medical_specialtyHypertension PulmonaryVentricular Dysfunction RightCognitive NeuroscienceSleep REMSettore MED/10 - Malattie Dell'Apparato RespiratorioBehavioral Neurosciencestomatognathic systemPhysiology (medical)Internal medicinemedicine.arteryHumansMedicineRespiratory functionWakefulnessHypoxiaPulmonary wedge pressureLungSleep Apnea Obstructivebusiness.industryHemodynamicsSleep apneaGeneral MedicineStroke volumeHypoxia (medical)medicine.diseasePulmonary artery pressurePulmonary hypertensionnervous system diseasesrespiratory tract diseasesObstructive sleep apneaOphthalmologyStroke volumemedicine.anatomical_structureNeurologyObstructive sleep apnoeaVentricleAnesthesiaPulmonary arteryDentistry (all)CardiologyRight ventricleNeurology (clinical)medicine.symptombusinessJournal of sleep research
researchProduct

Infantile Central Sleep Apnea - Improvement With Acetazolamide

1999

Central sleep apneabusiness.industryAnesthesiaPediatrics Perinatology and Child HealthMedicinebusinessmedicine.diseaseAcetazolamidemedicine.drugPediatric Research
researchProduct

Sleep disordered breathing in medically stable patients with myasthenia gravis

2007

We investigate sleep and breathing in clinically stable myasthenia gravis (MG) patients and ask weather sleep disordered breathing (SDB) is causally linked with MG. Nineteen MG patients with a mean disease duration of 9.7 years underwent sleep studies in two consecutive nights. The primary outcome measure was the respiratory disturbance index (RDI) in terms of snoring and apneas/hypopneas. Further outcome measurements were total sleep time, sleep stage distribution and the number of arousals. A clinically relevant SDB in terms of obstructive sleep apnea (OSA) (defined as RDI > 10/h) was found in four patients. There were only a few central apneas (central apnea index: 0.19 +/- 0.4/h). We di…

Central sleep apneabusiness.industryCentral apneaSleep apneamedicine.diseaseSleep in non-human animalsMyasthenia gravisnervous system diseasesrespiratory tract diseasesObstructive sleep apneaNeurologySleep and breathingAnesthesiaRespiratory disturbance indexMedicineNeurology (clinical)businessEuropean Journal of Neurology
researchProduct

Effects of adenotonsillectomy on neurocognitive and behavioural function in pediatric obstructive sleep apnea syndrome

2018

Effects of adenotonsillectomy on neurocognitive and behavioural function in pediatric obstructive sleep apnea syndrome. Objectives: Aim of this study is to verify the presence of neurocognitive, neurobehavioral or sleep disturbances in children affected by adenotonsillar hypertrophy (ATH) and Obstructive Sleep Apnea Syndrome (OSAS) and verify their improvement after Adeno-Tonsillectomy (AT). Methods: Eighty children suffering from adenotonsillar hypertrophy and OSAS were recruited for AT in the ENT Department of the University of Palermo. All the children underwent clinical evaluation, including rhinofibroscopy for grading the obstruction due to the adenotonsillar hypertrophy (before and 6 …

Children's behavioral disturbanceAdenotonsillar hypertrophyKey-words. sleep breathing disorderOtorhinolaryngology2734 Pathology and Forensic MedicineObstructive sleep apnea
researchProduct

Effects of sleep apnea and kidney dysfunction on objective sleep quality in nondialyzed patients with chronic kidney disease: an ESADA study

2020

Study Objectives: Patients with chronic kidney disease (CKD) often report poor sleep quality, but they commonly exhibit OSA. The aim of this study was to evaluate the influence of OSA severity and of estimated glomerular filtration rate impairment on objective sleep quality in nondialyzed patients with CKD, defined as an estimated glomerular filtration rate <60 mL/min/1.73m2. Methods: Polysomnographic sleep characteristics were compared between patients with (n = 430) and without CKD (n = 6,639) in the European Sleep Apnea Database cohort. Comparisons were repeated in 375 patients with CKD and 375 control patients without CKD matched for sleep center, age, sex, and AHI, and in 310 matche…

Chronic kidney disease ; Estimated glomerular filtration rate ; Sleep apnea ; Sleep qualitysleep quality.Pulmonary and Respiratory Medicinemedicine.medical_specialtyRenal functionSettore MED/10 - Malattie Dell'Apparato RespiratorioKidneyurologic and male genital diseases03 medical and health sciencesSleep Apnea Syndromes0302 clinical medicinestomatognathic systemChronic kidney diseaseInternal medicineHumansMedicineEstimated glomerular filtration rateRenal Insufficiency ChronicSleep Apnea ObstructiveSleep qualitybusiness.industrySleep apneaKidney dysfunctionSleep apneaSleep qualitymedicine.diseaseScientific Investigationsfemale genital diseases and pregnancy complicationsnervous system diseasesrespiratory tract diseasesPoor sleep030228 respiratory systemNeurologyHuman medicineNeurology (clinical)Sleepbusiness030217 neurology & neurosurgeryKidney diseaseJournal of Clinical Sleep Medicine
researchProduct

Medico-legal implications of sleep apnoea syndrome: driving license regulations in Europe.

2008

Background: Sleep apnoea syndrome (SAS), one of the main medical causes of excessive daytime sleepiness, has been shown to be a risk factor for traffic accidents. Treating SAS results in a normalized rate of traffic accidents. As part of the COST Action B-26, we looked at driving license regulations, and especially at its medical aspects in the European region. Methods: We obtained data from Transport Authorities in 25 countries (Austria, AT; Belgium, BE; Czech Republic, CZ; Denmark, DK; Estonia, EE; Finland, FI; France, FR; Germany, DE; Greece, GR; Hungary, HU; Ireland, IE; Italy, IT; Lithuania, LT; Luxembourg, LU; Malta, MT; Netherlands, NL; Norway, EC; Poland, PL; Portugal, PT; Slovakia,…

Cross-Cultural Comparisonmedicine.medical_specialtyPediatricsAutomobile DrivingSleep ApneaDriving license regulationsExcessive daytime sleepinessPoison controlDisorders of Excessive SomnolenceSettore MED/10 - Malattie Dell'Apparato RespiratorioOccupational safety and healthRisk FactorsInjury preventionmedicineHumansPsychiatryLicenseSleep Apnea ObstructiveTraffic/legislation & jurisprudencebusiness.industryAccidents TrafficSleep apneaDisorders of Excessive Somnolence/complicationsGeneral MedicineSleep Apnea Obstructive/complicationsmedicine.diseaseEuropeObstructive sleep apnoeaAccidents Traffic/legislation & jurisprudenceAccidentsCost action sleep apneaMedical certificateObstructive/complicationsmedicine.symptombusinessAutomobile Driving/legislation & jurisprudenceNarcolepsySleep medicine
researchProduct